Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
Effective maintenance and care after the intensive phases of leukemia treatment is essential for sustaining remission and improving long‑term outcomes. At Liv Hospital, we combine cutting‑edge medical protocols with personalized support to ensure that international patients receive seamless follow‑up throughout their recovery journey. Recent studies show that patients who adhere to structured maintenance programs have up to a 30% lower risk of relapse compared with those who receive inconsistent follow‑up.
This page is designed for individuals who have completed induction or consolidation therapy for leukemia and are looking for clear guidance on post‑treatment strategies. We will explore the components of maintenance therapy, strategies for managing side effects, nutrition and lifestyle recommendations, monitoring schedules, psychological support, and how Liv Hospital’s dedicated international patient services facilitate a smooth transition to long‑term care.
Whether you are newly entering the maintenance phase or seeking to optimize an existing plan, the information below provides a comprehensive roadmap to help you stay proactive, comfortable, and confident in your ongoing health journey.
Maintenance therapy is a low‑intensity treatment designed to eradicate any residual leukemic cells that may remain after the initial intensive phases. The goal is to keep the disease in remission while minimizing toxicity. Common modalities include oral chemotherapeutic agents, targeted therapies, and low‑dose intravenous regimens.
Regimen Type | Administration | Typical Duration | Primary Indication
|
|---|---|---|---|
Oral Chemotherapy | Daily oral pills | 12–24 months | Acute lymphoblastic leukemia (ALL) |
Targeted Therapy | Oral or sub‑cutaneous | Indefinite | Chronic myeloid leukemia (CML) |
Low‑Dose IV | Monthly infusion | 6–12 months | Acute myeloid leukemia (AML) in remission |
Choosing the right regimen depends on leukemia subtype, genetic markers, and patient tolerance. At Liv Hospital, a multidisciplinary team—including hematologists, pharmacists, and nursing specialists—evaluates each case to tailor a maintenance plan that balances efficacy with quality of life.
Even low‑intensity maintenance regimens can produce side effects that affect daily activities. Proactive management reduces the likelihood of dose reductions or interruptions, preserving the therapeutic benefit.
Liv Hospital provides a dedicated side‑effect clinic where nurses conduct regular assessments, adjust supportive medications, and educate patients on self‑care techniques. Early intervention is critical; patients are encouraged to report any new or worsening symptoms promptly.
Nutrition plays a pivotal role in supporting the immune system and mitigating treatment‑related toxicity. A balanced diet can also help maintain a healthy weight, which is associated with better treatment tolerance.
Physical activity, tailored to individual stamina, is also encouraged. Light walking, yoga, or supervised physiotherapy sessions improve circulation, reduce fatigue, and enhance mood. Liv Hospital’s nutritionists create personalized meal plans that consider cultural preferences and any dietary restrictions, ensuring patients receive both comfort and optimal nutrient intake.
Regular monitoring enables early detection of relapse and assessment of treatment tolerability. A structured follow‑up schedule typically includes laboratory tests, imaging, and clinical evaluations.
Time Point | Tests Performed | Purpose
|
|---|---|---|
Weeks 1–4 | CBC, metabolic panel, drug levels | Assess immediate toxicity and dose adjustment |
Months 3, 6, 12 | Bone marrow aspirate (if indicated), molecular markers | Evaluate minimal residual disease (MRD) |
Every 6 months thereafter | Imaging (CT/PET), cardiac echo (if cardiotoxic agents used) | Long‑term organ surveillance |
Patients receive electronic reminders and can access results through Liv Hospital’s secure patient portal. The portal also allows direct messaging with the care team, facilitating rapid response to any concerns.
Living with leukemia, even in remission, can generate anxiety, depression, and fear of recurrence. Comprehensive psychological support is a cornerstone of maintenance and care, aiming to preserve mental well‑being alongside physical health.
Liv Hospital integrates these services into the treatment plan, offering flexible scheduling to accommodate different time zones. Evidence shows that patients who engage in regular psychological care report higher adherence to maintenance therapy and better overall quality of life.
For patients traveling to Istanbul for their leukemia maintenance program, Liv Hospital provides a 360‑degree support system that removes logistical barriers and allows focus on health.
These services ensure that the maintenance and care journey is as comfortable and efficient as possible, aligning with Liv Hospital’s commitment to world‑class, patient‑centered care.
Liv Hospital is a JCI‑accredited private hospital in Istanbul that specializes in comprehensive cancer care for international patients. Our multidisciplinary teams combine advanced medical technology with personalized support services, ranging from interpreter assistance to accommodation coordination. By choosing Liv Hospital, patients benefit from evidence‑based treatment protocols, a seamless international patient experience, and a commitment to safety and excellence throughout every stage of maintenance and care.
Ready to start your personalized maintenance and care plan? Contact Liv Hospital today to schedule a consultation with our leukemia specialists and let our international patient team guide you every step of the way.
Send us all your questions or requests, and our expert team will assist you.
After the intensive induction and consolidation phases, some leukemic cells may remain undetectable. Maintenance therapy uses low‑intensity treatments—such as oral chemotherapy, targeted agents, or low‑dose IV infusions—to suppress these cells, prolong remission, and reduce the risk of relapse. Because the regimens are less aggressive, they are better tolerated, allowing patients to stay on therapy for months or even years while maintaining quality of life.
Even low‑dose regimens can cause fatigue, nausea, oral mucositis, cytopenias, and skin reactions. Patients should schedule short, frequent rest periods and engage in light aerobic activity to combat fatigue. Anti‑emetic medication before dosing and small bland meals help control nausea. Rigorous oral hygiene and saline rinses reduce mucositis. Weekly CBC checks allow early detection of low blood counts, with growth‑factor support if needed. For skin rash, hypoallergenic moisturizers and dermatologist‑prescribed topical steroids are effective. Prompt reporting to the side‑effect clinic enables rapid adjustments.
Nutrition supports immune function and treatment tolerance. Patients are encouraged to consume lean proteins (meat, fish, legumes, dairy) for tissue repair, complex carbohydrates (whole grains, oats, sweet potatoes) for steady energy, and omega‑3 rich fats (walnuts, flaxseeds, olive oil) to reduce inflammation. Hydration of 2–3 L daily is essential, adjusted for activity level. Processed sugars and excessive red meat should be limited because they can increase inflammatory markers. Personalized meal plans consider cultural preferences and any dietary restrictions.
The follow‑up timeline begins with weekly complete blood counts, metabolic panels, and drug‑level checks during weeks 1–4 to assess immediate toxicity and adjust doses. At months 3, 6, and 12, bone‑marrow aspirates (if indicated) and molecular marker tests evaluate minimal residual disease. After the first year, imaging studies (CT/PET) and organ‑function tests such as cardiac echo are performed every six months to monitor long‑term organ health. Results are delivered via a secure patient portal with electronic reminders.
Liv Hospital integrates comprehensive mental‑health care into the maintenance plan. Patients can access one‑on‑one counseling with oncology‑trained psychologists, join multilingual support groups for international patients, and participate in mindfulness, meditation, and breathing‑exercise workshops. Family counseling helps caregivers manage stress and support the patient effectively. Studies show that regular psychological care improves therapy adherence and overall quality of life.
Cancer
Cancer
Cancer
Cancer
Cancer
Cancer
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)